Navegar por autor "Poveda López, Eva"

Antiretroviral Treatment for HIV Elite Controllers?

2020- Ruiz-Mateos, E.; Poveda López, Eva; Lederman, M. M.

Any Risk for HIV Patients Posed by the Novel Influenza A (H7N9)?

2013- Poveda López, Eva

Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study

2019- Lakoh, S.; Jiba, D. F.; Kanu, J. E.; Poveda López, Eva; Salgado Barreira, Angel; [et al.]

Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

2019- De Mendoza, C.; Piron, M.; Jimenez, A.; Caballero, E.; Roc, L.; [et al.]

Diagnosis and treatment outcomes of adult tuberculosis in an urban setting with high HIV prevalence in Sierra Leone: A retrospective study

2020- Lakoh, S.; Jiba, D. F.; Adekanmbi, O.; Poveda López, Eva; Sahr, F.; [et al.]

Discovery of a Natural Defense Against HIV With Therapeutic Potential

2015- Poveda López, Eva

Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers

2024-08-29- Poveda López, Eva; Fitzgerald, Wendy; Alonso-Domínguez, Jacobo; Aguayo-Arjona, José; Mariño Callejo, Ana Isabel; [et al.]

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study

2014- García, Federico; Poveda López, Eva; Jesús Pérez-Elías, María; Hernández Quero, José; Ángels Ribas, María; [et al.]

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response

2014- Pertega Diaz, Sonia; López Calvo, Soledad; Castro Iglesias, Angeles; Pedreira Andrade, José Domingo; Cañizares Castellanos, Angelina; [et al.]

IMPACT OF HCV INFECTION IN A HIV COHORT FOLLOWED OVER 18 YEARS: PAST AND PRESENT

2015- Vázquez Rodríguez, Pilar; López Calvo, Soledad; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; [et al.]

Ingenol derivates promising for HIV eradication

2014- Poveda López, Eva

Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

2023-06-15- Poveda López, Eva; Fitzgerald, Wendy; Martínez Reglero, Cristina; Perez Gonzalez, Alexandre; Mariño Callejo, Ana Isabel; [et al.]

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

2023-10-18- Álvarez Díaz, Hortensia; Gutiérrez-Valencia, Alicia; Mariño Callejo, Ana Isabel; Saborido-Alconchel, Abraham; Calderón-Cruz, Beatriz; [et al.]

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines

2019- Cid Silva, Purificación; Margusino Framinan, Luis; Balboa Barreiro, Vanesa; Pernas Souto, Berta; Mena de Cea, Alvaro; [et al.]

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

2019- Cid Silva, Purificación; Margusino Framinan, Luis; Balboa Barreiro, Vanesa; Pernas Souto, Berta; Mena de Cea, Alvaro; [et al.]

Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study

2022- Perez Gonzalez, Alexandre; Araújo-Ameijeiras, A.; Fernández Villar, José Alberto; Crespo, M.; Poveda López, Eva [et al.]

Repositorio digital RUNA

Navegar por autor "Poveda López, Eva"

Antiretroviral Treatment for HIV Elite Controllers? ﻿

Any Risk for HIV Patients Posed by the Novel Influenza A (H7N9)? ﻿

Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study ﻿

Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain ﻿

Diagnosis and treatment outcomes of adult tuberculosis in an urban setting with high HIV prevalence in Sierra Leone: A retrospective study ﻿

Discovery of a Natural Defense Against HIV With Therapeutic Potential ﻿

Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers ﻿

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study ﻿

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response ﻿

Highlights from CROI 2014 on experimental HIV drugs ﻿

HIV tropism shift: new paradigm on cell therapy strategies for HIV cure ﻿

HIV-2 and HTLV-1 infections in Spain, a non-endemic region ﻿

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load. ﻿

IMPACT OF HCV INFECTION IN A HIV COHORT FOLLOWED OVER 18 YEARS: PAST AND PRESENT ﻿

Ingenol derivates promising for HIV eradication ﻿

Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1 ﻿

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors ﻿

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines ﻿

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines. ﻿

Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study ﻿

Antiretroviral Treatment for HIV Elite Controllers?

Any Risk for HIV Patients Posed by the Novel Influenza A (H7N9)?

Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study

Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

Diagnosis and treatment outcomes of adult tuberculosis in an urban setting with high HIV prevalence in Sierra Leone: A retrospective study

Discovery of a Natural Defense Against HIV With Therapeutic Potential

Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response

Highlights from CROI 2014 on experimental HIV drugs

HIV tropism shift: new paradigm on cell therapy strategies for HIV cure

HIV-2 and HTLV-1 infections in Spain, a non-endemic region

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.

IMPACT OF HCV INFECTION IN A HIV COHORT FOLLOWED OVER 18 YEARS: PAST AND PRESENT

Ingenol derivates promising for HIV eradication

Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study